GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1476 - 1500 of 4050 in total
Antibody Patient Onset (days) Symptom ▲ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 3 11 mild
G92823JK
355
IgA Patient 3 11 mild
G93351GM
457
IgA Patient 3 11 mild
G94435QH
392
IgA Patient 3 11 mild
G94576MN
434
IgA Patient 3 11 mild
G96557TJ
438
IgA Patient 3 11 mild
G96865DJ
11723
IgA Patient 3 11 mild
G96881BQ
389
IgA Patient 3 11 mild
G98068PA
3067
IgA Patient 3 11 mild
G98240FC
388
IgA Patient 3 11 mild
G99603GB
4076
IgG Patient 3 -180 mild
G00048MO
40
IgG Patient 3 -180 mild
G00051MO
63
IgG Patient 3 -180 mild
G00052MO
47
IgG Patient 3 -180 mild
G00053MO
38
IgG Patient 3 -180 mild
G00054MO
44
IgG Patient 3 -180 mild
G00057MO
84
IgG Patient 3 -180 mild
G00065MO
49
IgG Patient 3 -180 mild
G00066MO
81
IgG Patient 3 -180 mild
G00068MO
73
IgG Patient 3 -180 mild
G02557XE
46
IgG Patient 3 -180 mild
G02670IJ
44
IgG Patient 3 -180 mild
G03499BP
50
IgG Patient 3 -180 mild
G07483YN
54
IgG Patient 3 -180 mild
G08340FW
2275
IgG Patient 3 -180 mild
G08520NM
58

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024